These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33182795)

  • 1. The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.
    Clarke AL; De Soir S; Jones JD
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33182795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.
    Steele A; Stacey HJ; de Soir S; Jones JD
    Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33138253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Safety and Efficacy of Phage Therapy for Infections in Cardiac and Peripheral Vascular Surgery: A Systematic Review.
    Simpson EA; MacLeod CS; Stacey HJ; Nagy J; Jones JD
    Antibiotics (Basel); 2023 Nov; 12(12):. PubMed ID: 38136718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
    Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of bone and periprosthetic infections with bacteriophages : A systematic review].
    Walter N; Deng L; Brochhausen C; Alt V; Rupp M
    Orthopade; 2022 Feb; 51(2):138-145. PubMed ID: 34499212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections.
    Suh GA; Ferry T; Abdel MP
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S407-S415. PubMed ID: 37932115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety.
    Genevière J; McCallin S; Huttner A; Pham TT; Suva D
    EFORT Open Rev; 2021 Dec; 6(12):1148-1156. PubMed ID: 35003759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.
    Akanda ZZ; Taha M; Abdelbary H
    J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials.
    Stacey HJ; De Soir S; Jones JD
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens.
    Al-Ishaq RK; Skariah S; Büsselberg D
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy Administration Route, Regimen, and Need for Supplementary Antibiotics in Patients with Chronic Suppurative Lung Disease.
    Williams J; Severin J; Temperton B; Mitchelmore PJ
    Phage (New Rochelle); 2023 Mar; 4(1):4-10. PubMed ID: 37214654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
    Abedon ST
    Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31614449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategies for bacteriophages to target intracellular bacterial pathogens.
    Yan W; Banerjee P; Xu M; Mukhopadhyay S; Ip M; Carrigy NB; Lechuga-Ballesteros D; To KKW; Leung SSY
    Adv Drug Deliv Rev; 2021 Sep; 176():113864. PubMed ID: 34271022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.